Sign in

NCT03264261Recruiting

Constraint Induced Movement Therapy for Walking in Individuals Post Stroke

Source: ClinicalTrials.gov · Last updated 3 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To compare the effect of constraint induced movement therapy (CIMT) vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect. Subjects will be randomized to either the CIMT or treadmill training only groups at the initial test. Following the initial test, individuals from the 2 groups will undergo intensive locomotor training. Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated. Data collection will proceed until 36 subjects from 2 groups have been trained.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
36 (estimated)
First submitted
14 Aug 2017
Start date
14 Aug 2017
Primary completion date
30 Jul 2025
Lead sponsor
Shirley Ryan AbilityLab
Diseases
Stroke
NCT number
NCT03264261

What you commit to

  • Study type: Interventional
  • Planned participants: 36
  • From 14 Aug 2017 to the primary completion date, 30 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • significant cardiorespiratory/metabolic disease;
  • stroke of the brainstem or cerebellar lesions;
  • uncontrolled hypertension (systolic \> 200 mm Hg, diastolic \> 110 mm Hg);

Other

  • other neurological or orthopedic injury that impairs locomotion;
  • scores on the Mini Mental Status examination \< 24;
  • botox injection within 6 months of starting the study.

Who the study is looking for

  • age between 21 and 75 years;
  • history of unilateral, supratentorial, ischemic or hemorrhagic stroke;
  • no prior stroke;
  • demonstration of impaired walking function (self-selected walking speed ≤ 0.80 m/s);
  • able to stand and walk (\>10 meters) without physical assistance.

Age in the registry: 21 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Abilitylab
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.